Document Preview
  • Full Text
  • Scholarly Journal

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

; et al.
; View all authors. 
; Ann Arbor Vol. 123, Iss. 10,  (Oct 2013): 4144-57.